Lansoprazole
Product Images NDC 45865-879

4 FDA label images from Medsource Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Lansoprazole (NDC 45865-879). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medsource Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (879)

Pdp (879)
Lansoprazole DR Capsules 15 mg label from medsource pharmaceuticals. The label indicates the product is a generic for Prevacid, with a quantity of 60 capsules. The capsules are described as pink/green oblong with red and blue markings. Manufacturer is Dr. Reddy's Labs Ltd., India. Directions suggest avoiding alcohol and taking capsules multiple times daily.*
FDA Label Image

Figure1 (Figure1)

Figure1 (Figure1)
A line graph titled 'Mean Severity of Day Heartburn By Study Day For Evaluable Patients.' It compares mean severity scores of heartburn over approximately 60 days from treatment start among three groups: placebo, Lansoprazole 15 mg QD, and Lansoprazole 30 mg QD. Severity is rated on a scale where 3=Severe, 2=Moderate, 1=Mild, and 0=None. Both Lansoprazole groups show a reduction in heartburn severity compared to placebo over time.*
FDA Label Image

Figure2 (Figure2)

Figure2 (Figure2)
A line graph showing the mean severity of night heartburn over time by study day for evaluable patients comparing placebo, lansoprazole 15 mg once daily, and lansoprazole 30 mg once daily. The y-axis represents mean severity on a scale from 0 (None) to 3 (Severe), and the x-axis shows days from start of treatment, ranging from 0 to 60 days.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of lansoprazole, showing the molecular arrangement including a benzimidazole ring, sulfoxide group, and substituted pyridine ring with trifluoromethoxy and methyl groups, consistent with its active ingredient chemistry.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.